Back to RecallTracker
Health Canada Health products

Baxter Intravenous Solution Bags – Potential Leak During Spiking of Administration Port

Issued October 6, 2023
Issue
Intravenous bags of Baxter’s 0.4% Lidocaine & 5% Dextrose Injection 250 mL, 0.9% Sodium Chloride Injection, USP 100 mL and 250 mL, Lactated Ringer’s Injection, USP 250 mL, and Metronidazole Injection, USP 100mL from certain lots have the potential to leak during the process of spiking the administration port. The affected lots identified in Appendix A are not being recalled at this time in order to prevent a shortage of these medically necessary products.
Hazard description
Product quality - Product safety
Product
Product name
0.4% Lidocaine & 5% Dextrose Injection, 0.9% Sodium Chloride Injection, USP, Lactated Ringer’s Injection, USP, and Metronidazole Injection, USP
Reference
ID
RA-74389